Reuters logo
BRIEF-Ocular and Regeneron enter into strategic collaboration to develop sustained release formulation of aflibercept
2016年10月13日 / 中午11点32分 / 1 年前

BRIEF-Ocular and Regeneron enter into strategic collaboration to develop sustained release formulation of aflibercept

Oct 13 (Reuters) - Ocular Therapeutix Inc :

* Ocular Therapeutix(tm) and Regeneron enter into strategic collaboration to develop sustained release formulation of aflibercept for the treatment of wet AMD and other serious retinal diseases

* Ocular Therapeutix Inc - eligible to receive up to $305 million in milestone payments in addition to royalties on potential future net sales Source text for Eikon: Further company coverage: ;))

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below